Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

CONTEXT: Postprandial hyperglycemia remains a challenge in type 1 diabetes (T1D) due, in part, to dysregulated increases in plasma glucagon levels after meals. OBJECTIVE: This study was undertaken to examine whether 3 to 4 weeks of therapy with pramlintide or liraglutide might help to blunt postpran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Galderisi, Alfonso, Sherr, Jennifer, VanName, Michelle, Carria, Lori, Zgorski, Melinda, Tichy, Eileen, Weyman, Kate, Cengiz, Eda, Weinzimer, Stuart, Tamborlane, William
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2017
Assuntos:
Clinical Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276715/
https://ncbi.nlm.nih.gov/pubmed/29211871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2017-02265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados